GSK3B and acute liver failure: Inhibition of GSK3β has been reported as an effective hepatoprotective approach for liver injury induced by ischemia-reperfusion [39] as well as for acute liver failure (ALF) induced by D-galactosamine and lipopolysaccharide (D-GalN/LPS) [31].